← Back to Search

Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study

N/A
Recruiting
Led By Laura Gibson, MD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up stage i up to 2 years
Awards & highlights
No Placebo-Only Group

Summary

The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one saliva sample for CMV PCR testing. In addition, infrastructure for the study will be developed (e.g. community engagement to build the network of centers, data pipelines, digital platform, sampling workflows) and participant sample collection at home will be piloted. These activities will inform the design of STAGE II.

Eligible Conditions
  • Cytomegalovirus Infection
  • Cytomegalovirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~stage i up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and stage i up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prevalence of CMV shedding

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: StaffExperimental Treatment1 Intervention
All staff members in large group childcare centers attended by children participants
Group II: ChildrenExperimental Treatment1 Intervention
Children up to and including 36 months in large group childcare centers in the study network

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
362 Previous Clinical Trials
992,620 Total Patients Enrolled
ModernaTX, Inc.Industry Sponsor
121 Previous Clinical Trials
66,784,974 Total Patients Enrolled
Laura Gibson, MDPrincipal InvestigatorUMass Chan Medical School
~59 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top